Friday, August 3, 2018

BNP Paribas Arbitrage SA Increases Holdings in Abercrombie & Fitch Co. (ANF)

BNP Paribas Arbitrage SA raised its stake in Abercrombie & Fitch Co. (NYSE:ANF) by 122.7% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 204,571 shares of the apparel retailer’s stock after acquiring an additional 112,729 shares during the period. BNP Paribas Arbitrage SA owned approximately 0.30% of Abercrombie & Fitch worth $5,008,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. BlackRock Inc. increased its holdings in Abercrombie & Fitch by 4.3% in the 1st quarter. BlackRock Inc. now owns 9,246,433 shares of the apparel retailer’s stock valued at $223,856,000 after acquiring an additional 377,954 shares during the last quarter. Paradice Investment Management LLC grew its stake in shares of Abercrombie & Fitch by 3.2% in the 1st quarter. Paradice Investment Management LLC now owns 2,718,069 shares of the apparel retailer’s stock worth $65,777,000 after buying an additional 83,438 shares in the last quarter. Robeco Institutional Asset Management B.V. grew its stake in shares of Abercrombie & Fitch by 1.0% in the 1st quarter. Robeco Institutional Asset Management B.V. now owns 1,228,734 shares of the apparel retailer’s stock worth $29,749,000 after buying an additional 12,528 shares in the last quarter. Copper Rock Capital Partners LLC purchased a new position in shares of Abercrombie & Fitch in the 2nd quarter worth $19,833,000. Finally, Geode Capital Management LLC grew its stake in shares of Abercrombie & Fitch by 0.6% in the 4th quarter. Geode Capital Management LLC now owns 564,238 shares of the apparel retailer’s stock worth $9,834,000 after buying an additional 3,539 shares in the last quarter.

Get Abercrombie & Fitch alerts:

A number of brokerages have commented on ANF. TheStreet raised shares of Abercrombie & Fitch from a “c” rating to a “b-” rating in a research note on Thursday, May 17th. Wedbush began coverage on shares of Abercrombie & Fitch in a research note on Thursday, May 10th. They issued a “neutral” rating and a $25.00 price objective for the company. ValuEngine raised shares of Abercrombie & Fitch from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, May 2nd. Zacks Investment Research raised shares of Abercrombie & Fitch from a “hold” rating to a “buy” rating and set a $26.00 price objective for the company in a research note on Tuesday. Finally, JPMorgan Chase & Co. dropped their price objective on shares of Abercrombie & Fitch from $23.00 to $22.00 and set an “underweight” rating for the company in a research note on Monday, June 4th. Five equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and five have given a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $21.01.

Abercrombie & Fitch opened at $24.19 on Friday, Marketbeat Ratings reports. Abercrombie & Fitch Co. has a 12 month low of $9.03 and a 12 month high of $29.20. The company has a debt-to-equity ratio of 0.25, a current ratio of 2.54 and a quick ratio of 1.67. The stock has a market cap of $1.61 billion, a P/E ratio of 37.22, a PEG ratio of 2.32 and a beta of 0.72.

Abercrombie & Fitch (NYSE:ANF) last released its quarterly earnings results on Friday, June 1st. The apparel retailer reported ($0.56) EPS for the quarter, topping analysts’ consensus estimates of ($0.77) by $0.21. Abercrombie & Fitch had a net margin of 0.74% and a return on equity of 5.72%. The firm had revenue of $730.90 million during the quarter, compared to analysts’ expectations of $695.68 million. During the same period in the previous year, the company earned ($0.91) EPS. The firm’s revenue for the quarter was up 10.6% compared to the same quarter last year. research analysts expect that Abercrombie & Fitch Co. will post 0.82 earnings per share for the current year.

In related news, insider Stacia J.P. Andersen sold 28,000 shares of Abercrombie & Fitch stock in a transaction dated Wednesday, June 20th. The shares were sold at an average price of $27.55, for a total transaction of $771,400.00. Following the completion of the transaction, the insider now directly owns 18,251 shares of the company’s stock, valued at approximately $502,815.05. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Kerrii B. Anderson purchased 2,000 shares of the company’s stock in a transaction that occurred on Tuesday, June 5th. The shares were purchased at an average cost of $24.03 per share, with a total value of $48,060.00. Following the completion of the purchase, the director now owns 2,500 shares in the company, valued at approximately $60,075. The disclosure for this purchase can be found here. 0.95% of the stock is currently owned by insiders.

About Abercrombie & Fitch

Abercrombie & Fitch Co, through its subsidiaries, operates as a specialty retailer. The Company operates in two segments, Hollister and Abercrombie. It offers apparel, intimates, personal care products, and accessories for men, women, and kids under the Hollister, Abercrombie & Fitch, abercrombie kids, and Gilly Hicks brand names.

Read More: Short Selling Stocks and Day Traders

Want to see what other hedge funds are holding ANF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Abercrombie & Fitch Co. (NYSE:ANF).

Institutional Ownership by Quarter for Abercrombie & Fitch (NYSE:ANF)

Wednesday, August 1, 2018

Three obscure charts are pointing to weakness for stocks

All it takes is a peek under the market��s hood to see several warning signs cropping up for stocks.

Specifically, three measures of breadth, including the number of stocks advancing relative to the number declining �� a way to take the market��s temperature �� have been experiencing some meaningful cracks recently.

We��ve all heard about how a small number of high-flying stocks have accounted for most of the market��s gains this year, but in fact the NYSE cumulative advance/decline line had actually been rallying quite nicely along with the market for most of the year. Although the so-called FAANG stocks and a few other large-cap momentum names have played a big role in the rally, the advance has not been as ��narrow�� as many have tried to portray �� until now.

The action in the advancers vs. decliners in the S&P 500 has been was disappointing. Despite a 13-point rally in the S&P 500 on Tuesday, the number of advancers was actually lower than the decliners in the S&P and the broader NYSE Composite Index. So there's no question that the most recent advance in the stock market is being fueled by fewer and fewer names.

Then, there��s the percentage of stocks trading above their 200-day moving averages. That measure is rolling over, and stands well below where it was during the January highs.

Finally, the moving average convergence-divergence indicator on the NYSE advance/decline line is seeing a negative cross at a lower level than it did in June. In other words, ��lower lows�� are never good on a chart.

What do all of these indicators add up to? Consider this. When a rally in the stock market becomes narrower, it is usually a sign that the rally is running out of gas. No, it does not mean that the nine-year bull market is about to crash to an end, but it is probably telling us that the stock market should be due to see a pullback soon.

Therefore, continued breadth deterioration would be a sign investors should consider becoming a little less aggressive right now �� and look to buy on any dips, rather than chase the market at current levels.

Vote Vote to see results Total Votes:

Not a Scientific Survey. Results may not total 100% due to rounding.

Disclaimer

Saturday, July 21, 2018

Snapchat's Still Suffering at the Hands of Instagram

Ever since Instagram rolled out its Stories feature a couple years ago, Snap (NYSE:SNAP) has seen an impact on Snapchat user growth. But it's not just users that prefer Instagram Stories over Snap's -- it's advertisers, too. Ninety percent of marketers prefer advertising on Instagram Stories instead of Snapchat Stories, according to a recent survey from Cowen. That's actually a slight improvement from the beginning of the year.

More importantly, nearly half of all marketers in the survey said they spent less than anticipated on Snapchat ads during the first half of the year. Instagram, meanwhile, saw its spending intentions increase overall among the marketers surveyed.

With 1 billion total monthly users on Instagram, twice as many using Instagram Stories on a daily basis compared to Snapchat, and the power of Facebook (NASDAQ:FB) behind it, Instagram probably isn't done putting pressure on Snap's revenue.

Three smartphones showing screenshots of Instagram Stories

Image source: Instagram.

Stories ads are just getting started

Stories ads are a relatively new format for marketers. Snapchat's only been doing it for two years, and Instagram started offering ads in Stories last March. On Facebook's fourth-quarter earnings call earlier this year, COO Sheryl Sandberg described ads in Stories as "a small but quickly growing part of our revenue."

With Instagram's strong user growth and the relatively low ad load in Stories, there's still a lot of room for Facebook to grow its ad inventory. That's important, as marketers might prefer Instagram for its superior content and targeting capabilities, but will opt for competitors if prices climb too quickly.

Instagram has historically seen between 60% and 67% of its users log into the app daily. That implies over 200 million users are logging into the app, but not clicking on Stories, every day. That's low-hanging fruit for Facebook to convert into additional Stories users. So Instagram can avoid increasing ad load for now if it can encourage more users to click on Stories. It's already taken additional steps to do so, displaying friends' Stories in the middle of the regular feed.

Instagram being in the early stages for ads within Stories is bad news for Snap, which has struggled with engagement in the first half of the year following a botched redesign of the Snapchat app. As long as Instagram continues to expand its ad inventory, that means the preference for Instagram will continue to pressure Snap's top-line growth.

What can Snap do?

Snap isn't going to overcome Instagram's advantages anytime soon. Its best course of action is to do what management says is its only option in a market where products are distributed quickly and freely: innovate.

To that end, Snap has an advantage in augmented reality capabilities, and it's reportedly using it to create visual search capabilities within Snapchat. The new feature would enable users to shop for items they see in the real world simply by pointing their smartphone camera at them. That could potentially enable Snap to do to Instagram what Instagram did to it. Instagram is notably frequently used for shopping.

A visual search product could reinvigorate engagement and open new marketing opportunities for Snap. It's certainly one of the more promising products in Snap's pipeline, as it has real potential to differentiate the company's app from Facebook and other social apps.

But until Snap finds a way to truly differentiate its products -- both consumer-facing and marketer-facing -- it will likely continue to suffer at the hands of Instagram and Facebook.

Thursday, July 12, 2018

Kodak: Putting the CON in Confidence?

Keith Fitz-GeraldKeith Fitz-Gerald

I'm often asked how I know which companies to avoid – like the plague – or "sell short" in the name of big profits.

"You seem to have it down to a science," said Barbara P. and her husband, Robert, over coffee in Seattle recently…

Fitbit Inc. (NYSE: FIT) at $16.97 before it fell 71.66%…

Sears Holding Corp. (Nasdaq: SHLD) at $144.86 before it fell 98.4%…

GoPro Inc. (Nasdaq: GPRO) at $86.97 before it fell 94.5%…

They'd come to check out the original Starbucks Corp. (Nasdaq: SBUX) location in Pike Place Market after hearing me talk, during an appearance on "Varney & Co." a week ago, about why I think the company is in for some rough sledding in the months ahead.

"Science may be pushing it, but thank you for the compliment," I said… and I added that "the real secret is psychology."

Let me explain…

Logic Doesn't Apply When Emotion Takes Over

Market psychology is the feeling investors develop that compels them to buy or sell specific stocks. It's very different than technical knowledge or even a hot tip.

What I'm talking about is the emotional driver that prompts 'em to buy or sell. The former is usually an expression of optimism, while the latter is usually a reflection of inner fear. Either way, logic goes right out the window.

The key to big profits when this happens is finding companies where the two – logic and emotion – are at odds.

Take Eastman Kodak Co. (NYSE: KODK), for example.

The company is an unmitigated disaster and has been for decades because it missed the transition to digital photography despite the fact that it created much of the technology driving it today.

Start the Countdown: In just five days, you could have a fat check for $23,441 in your mailbox. The best part is, it's just one short phone call away. Over 80% of eligible seniors may be entitled to this cash. Are you one of them?

Not many people know, for example, that Kodak actually invented the first megapixel camera in 1986. That should have given them a huge lead because they were years ahead of the competition, but it didn't because executives failed to grasp the earth-shattering potential.

Here's another surprise… Kodak actually spent more than half a billion dollars in the mid-90s to develop the first digital preview cameras yet held back because management feared that releasing that technology would eat into the film business.

Other critical failures followed, including the misguided purchase of Sterling Drug in 1988 and a series of CEOs who just couldn't grasp the inevitability of digital images, much in the way former Microsoft CEO, Steve Ballmer, failed to understand Apple's iPhone when the late Steve Jobs unveiled it. (Which he ridiculed in this now famous clip from 2007.)

Kodak even purchased a photo-sharing site called Ofoto in 2001. That should have been an amazingly profitable springboard that allowed them to dominate today's social media a la Instagram or Twitter!

If you're like most investors, you're asking yourself… Ofoto???!!!!

My point… exactly.

Kodak has repeatedly made some really intelligent breakthroughs over the years only to shoot themselves in the proverbial foot every time.

Sales have fallen from $10.3 billion in 2007 to only $1.53 billion a decade later to 2017. Net income, over that same time frame, has dropped from $676 million to a staggering $94 million – a loss of 86.09% in a decade.

The company's stock has fallen by more than 60.1% in the past 12 months alone and a jaw-dropping 80.7% over the past five years during one of the biggest bull markets on record.

I think it'll hit zero in the next six months.

Psychology Is Your Key to Big Profits Ahead

Join the conversation. Click here to jump to comments…

Keith Fitz-GeraldKeith Fitz-Gerald

About the Author

Browse Keith's articles | View Keith's research services

Keith Fitz-Gerald has been the Chief Investment Strategist for the Money Morning team since 2007. He's a seasoned market analyst with decades of experience, and a highly accurate track record. Keith regularly travels the world in search of investment opportunities others don't yet see or understand. In addition to heading The Money Map Report, Keith runs High Velocity Profits, which aims to get in, target gains, and get out clean. In his weekly Total Wealth, Keith has broken down his 30-plus years of success into three parts: Trends, Risk Assessment, and Tactics �� meaning the exact techniques for making money. Sign up is free at totalwealthresearch.com.

… Read full bio

Tuesday, July 10, 2018

REBL (REBL) Achieves Market Capitalization of $6.82 Million

REBL (CURRENCY:REBL) traded 2.1% higher against the US dollar during the one day period ending at 8:00 AM E.T. on July 7th. One REBL token can currently be purchased for about $0.0400 or 0.00000608 BTC on major cryptocurrency exchanges including CoinFalcon, Token Store, EtherDelta (ForkDelta) and Bit-Z. During the last week, REBL has traded 4.1% higher against the US dollar. REBL has a market cap of $6.82 million and approximately $1.29 million worth of REBL was traded on exchanges in the last day.

Here is how similar cryptocurrencies have performed during the last day:

Get REBL alerts: XRP (XRP) traded 0.7% lower against the dollar and now trades at $0.47 or 0.00007181 BTC. Stellar (XLM) traded 0.4% higher against the dollar and now trades at $0.20 or 0.00003099 BTC. IOTA (MIOTA) traded 1% lower against the dollar and now trades at $1.07 or 0.00016297 BTC. Tether (USDT) traded down 0.1% against the dollar and now trades at $1.00 or 0.00015234 BTC. NEO (NEO) traded down 3.1% against the dollar and now trades at $37.29 or 0.00565997 BTC. TRON (TRX) traded 0.3% higher against the dollar and now trades at $0.0366 or 0.00000556 BTC. Binance Coin (BNB) traded 5.9% higher against the dollar and now trades at $14.26 or 0.00216377 BTC. VeChain (VET) traded up 1.8% against the dollar and now trades at $2.49 or 0.00037803 BTC. Ontology (ONT) traded down 1% against the dollar and now trades at $4.66 or 0.00070675 BTC. Zilliqa (ZIL) traded up 0.2% against the dollar and now trades at $0.0823 or 0.00001250 BTC.

REBL Token Profile

REBL was first traded on November 4th, 2017. REBL’s total supply is 326,480,305 tokens and its circulating supply is 170,376,386 tokens. The official website for REBL is www.rebellious.io. REBL’s official Twitter account is @RebelliousCoin. The Reddit community for REBL is /r/RebelliousCoin and the currency’s Github account can be viewed here.

Buying and Selling REBL

REBL can be traded on the following cryptocurrency exchanges: Bit-Z, EtherDelta (ForkDelta), CoinFalcon and Token Store. It is usually not presently possible to purchase alternative cryptocurrencies such as REBL directly using U.S. dollars. Investors seeking to trade REBL should first purchase Bitcoin or Ethereum using an exchange that deals in U.S. dollars such as Coinbase, Changelly or Gemini. Investors can then use their newly-acquired Bitcoin or Ethereum to purchase REBL using one of the exchanges listed above.

new TradingView.widget({ “height”: 400, “width”: 650, “symbol”: “REBLUSD”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Monday, July 9, 2018

Somewhat Positive News Coverage Somewhat Unlikely to Impact Spok (SPOK) Stock Price

News stories about Spok (NASDAQ:SPOK) have trended somewhat positive recently, Accern Sentiment reports. The research group rates the sentiment of news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Spok earned a coverage optimism score of 0.07 on Accern’s scale. Accern also gave news articles about the Wireless communications provider an impact score of 46.0015198315013 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Shares of Spok traded up $0.15, hitting $15.60, on Friday, Marketbeat Ratings reports. 77,900 shares of the stock were exchanged, compared to its average volume of 113,167. The stock has a market capitalization of $301.10 million, a P/E ratio of 35.23 and a beta of 0.56. Spok has a fifty-two week low of $13.75 and a fifty-two week high of $18.85.

Get Spok alerts:

Spok (NASDAQ:SPOK) last released its earnings results on Wednesday, April 25th. The Wireless communications provider reported $0.03 earnings per share (EPS) for the quarter. Spok had a positive return on equity of 2.84% and a negative net margin of 9.05%. The business had revenue of $43.11 million for the quarter.

The business also recently announced a quarterly dividend, which was paid on Friday, June 22nd. Investors of record on Friday, May 25th were issued a dividend of $0.125 per share. The ex-dividend date of this dividend was Thursday, May 24th. This represents a $0.50 annualized dividend and a yield of 3.21%.

Several research firms have recently weighed in on SPOK. BidaskClub cut Spok from a “sell” rating to a “strong sell” rating in a research report on Friday, June 15th. ValuEngine cut Spok from a “hold” rating to a “sell” rating in a research report on Wednesday, May 2nd.

In related news, CEO Vincent D. Kelly sold 10,000 shares of the company’s stock in a transaction dated Monday, June 4th. The stock was sold at an average price of $15.38, for a total transaction of $153,800.00. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Vincent D. Kelly sold 5,000 shares of the company’s stock in a transaction dated Friday, June 1st. The stock was sold at an average price of $15.39, for a total value of $76,950.00. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company’s stock.

Spok Company Profile

Spok Holdings, Inc, through its subsidiary, Spok, Inc, provides various communications solutions to healthcare, government, and other enterprises in the United States, Europe, Canada, Australia, Asia, and the Middle East. The company provides one-way messaging, including numeric messaging services, which enable subscribers to receive messages comprising numbers, such as phone numbers; and alphanumeric messages, including numbers and letters that enable subscribers to receive text messages.

Insider Buying and Selling by Quarter for Spok (NASDAQ:SPOK)

Saturday, July 7, 2018

Top 5 Penny Stocks To Own Right Now

tags:IRET,UMH,SAFM,PTI,SMSI,

Investors looking for the�best small-cap stock to buy�are often looking for the profit potential of penny stocks without the risk associated with over-the-counter exchanges.

Investing in penny stocks�can be exciting and massively profitable. But penny stocks can be too volatile and risky for some investors.

Consider one of the top penny stocks from December,�VistaGen Therapeutics Inc.�(Nasdaq: VTGN). VTGN shares soared 156% in a single day of trading on Dec. 6.

VistaGen is a clinical-stage pharmaceutical company based in California that develops treatments for central nervous system disorders like depression.

Top 5 Penny Stocks To Own Right Now: Investors Real Estate Trust(IRET)

Advisors' Opinion:
  • [By Shane Hupp]

    Get a free copy of the Zacks research report on INVESTORS REAL ESTATE TRUST REIT Common Stock (IRET)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Staff]

    Investors Real Estate Trust (NYSE:IRET) Q4 2018 Earnings Conference CallJun. 28, 2018 10:00 a.m. ET

    Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

    Operator

Top 5 Penny Stocks To Own Right Now: UMH Properties Inc.(UMH)

Advisors' Opinion:
  • [By Lisa Levin]

    Wednesday afternoon, the real estate shares surged 0.56 percent. Meanwhile, top gainers in the sector included Armada Hoffler Properties, Inc. (NYSE: AHH), up 3 percent, and UMH Properties, Inc. (NYSE: UMH) up 3 percent.

  • [By Joseph Griffin]

    WINTON GROUP Ltd bought a new stake in UMH PROPERTIES/SH SH (NYSE:UMH) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 86,705 shares of the real estate investment trust’s stock, valued at approximately $1,163,000. WINTON GROUP Ltd owned about 0.24% of UMH PROPERTIES/SH SH as of its most recent SEC filing.

Top 5 Penny Stocks To Own Right Now: Sanderson Farms Inc.(SAFM)

Advisors' Opinion:
  • [By Stephan Byrd]

    Shares of Sanderson Farms, Inc. (NASDAQ:SAFM) have been given a consensus recommendation of “Hold” by the thirteen research firms that are covering the stock, Marketbeat.com reports. Three research analysts have rated the stock with a sell recommendation, eight have given a hold recommendation and one has assigned a buy recommendation to the company. The average 12 month price target among analysts that have covered the stock in the last year is $111.75.

  • [By Lisa Levin]

    Breaking news

    Best Buy Co., Inc. (NYSE: BBY) reported better-than-expected earnings for its first quarter. Sanderson Farms, Inc. (NASDAQ: SAFM) reported weaker-than-expected results for its second quarter. Medtronic plc (NYSE: MDT) reported upbeat earnings for its fourth quarter on Thursday. Williams-Sonoma, Inc. (NYSE: WSM) reported stronger-than-expected results for its first quarter. The company also raised its FY18 earnings and sales guidance.

  • [By Stephan Byrd]

    Federated Investors Inc. PA cut its position in Sanderson Farms, Inc. (NASDAQ:SAFM) by 71.5% in the first quarter, HoldingsChannel reports. The firm owned 20,286 shares of the company’s stock after selling 51,010 shares during the quarter. Federated Investors Inc. PA’s holdings in Sanderson Farms were worth $2,415,000 at the end of the most recent reporting period.

  • [By Lisa Levin]

    Tuesday morning, the consumer staples shares surged 0.17 percent. Meanwhile, top gainers in the sector included CV Sciences, Inc. (OTC: CVSI), up 6 percent, and Sanderson Farms, Inc. (NASDAQ: SAFM) up 5 percent.

Top 5 Penny Stocks To Own Right Now: Patni Computer Systems Limited(PTI)

Advisors' Opinion:
  • [By Chris Lange]

    Proteostasis Therapeutics Inc. (NASDAQ: PTI) saw its shares slide early on Thursday after the company reported that it had positive data from its early stage trial in cystic fibrosis (CF). These results come from the firm��s ongoing Phase 1 dosing study of PTI-801 in CF patients on background Orkambi (lumacaftor/ivacaftor) therapy.

Top 5 Penny Stocks To Own Right Now: Smith Micro Software Inc.(SMSI)

Advisors' Opinion:
  • [By Stephan Byrd]

    These are some of the news stories that may have impacted Accern’s scoring:

    Get Smith Micro Software alerts: Short Interest in Smith Micro Software (SMSI) Increases By 51.9% (americanbankingnews.com) Smith Micro Software’s (SMSI) CEO Bill Smith on Q1 2018 Results – Earnings Call Transcript (seekingalpha.com) Smith Micro Software (SMSI) Reports Q1 Loss of $0.10 (streetinsider.com) Smith Micro Reports First Quarter 2018 Financial Results (finance.yahoo.com) Smith Micro announces above market USD 7.0m private placement offering (financial-news.co.uk)

    Separately, ValuEngine upgraded shares of Smith Micro Software from a “sell” rating to a “hold” rating in a report on Friday, February 2nd.

  • [By Shane Hupp]

    Okta (NASDAQ: OKTA) and Smith Micro Software (NASDAQ:SMSI) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.

Friday, July 6, 2018

Hot High Tech Stocks To Invest In Right Now

tags:BSD,ENPH,VTGN,AMPE,ITW,KOPN,

Xilinx (NASDAQ: XLNX) and NeoPhotonics (NYSE:NPTN) are both computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings and profitability.

Analyst Ratings

Get Xilinx alerts:

This is a breakdown of recent ratings and recommmendations for Xilinx and NeoPhotonics, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Xilinx 2 10 9 0 2.33 NeoPhotonics 0 5 4 1 2.60

Xilinx presently has a consensus price target of $74.00, suggesting a potential upside of 6.14%. NeoPhotonics has a consensus price target of $9.00, suggesting a potential upside of 27.48%. Given NeoPhotonics’ stronger consensus rating and higher probable upside, analysts plainly believe NeoPhotonics is more favorable than Xilinx.

Hot High Tech Stocks To Invest In Right Now: BlackRock Strategic Municipal Trust Inc. (BSD)

Advisors' Opinion:
  • [By Logan Wallace]

    BitSend (CURRENCY:BSD) traded 3.6% higher against the U.S. dollar during the one day period ending at 21:00 PM Eastern on June 2nd. One BitSend coin can currently be bought for approximately $0.53 or 0.00006976 BTC on popular cryptocurrency exchanges including Livecoin, Cryptopia, SouthXchange and LiteBit.eu. BitSend has a market cap of $10.33 million and approximately $22,076.00 worth of BitSend was traded on exchanges in the last 24 hours. In the last seven days, BitSend has traded up 2.3% against the U.S. dollar.

  • [By Ethan Ryder]

    BitSend (CURRENCY:BSD) traded down 8.9% against the U.S. dollar during the 1 day period ending at 16:00 PM Eastern on June 20th. During the last week, BitSend has traded 5.1% higher against the U.S. dollar. BitSend has a market cap of $6.58 million and approximately $147,698.00 worth of BitSend was traded on exchanges in the last 24 hours. One BitSend coin can now be purchased for approximately $0.34 or 0.00004993 BTC on major exchanges including LiteBit.eu, Cryptopia, SouthXchange and Bittrex.

Hot High Tech Stocks To Invest In Right Now: Enphase Energy, Inc.(ENPH)

Advisors' Opinion:
  • [By Dan Caplinger]

    The stock market fell on Wednesday, with the majority of closely followed benchmarks moving slightly lower. Market participants focused their attention on the latest decision from the Federal Reserve to raise short-term interest rates, moving their target for the fed funds rate up a quarter percentage point to a new range of 1.75% to 2%. Investors weren't sure about the macroeconomic implications of the Fed statement, which included calls for faster economic growth but also potentially more aggressive tightening in the future. Yet some companies had indisputably good news that sent their shares higher. Twenty-First Century Fox (NASDAQ:FOX) (NASDAQ:FOXA), Enphase Energy (NASDAQ:ENPH), and Korn/Ferry International (NYSE:KFY) were among the best performers on the day. Here's why they did so well.

  • [By Travis Hoium]

    Shares of microinverter Enphase Energy Inc (NASDAQ:ENPH) jumped as much as 38.4% in trading Wednesday after the company announced an important acquisition of SunPower's (NASDAQ:SPWR) microinverter business. Shares held steady with their gains throughout the day and were up 34% at 11:50 a.m. EDT.�

  • [By Logan Wallace]

    Enphase Energy (NASDAQ:ENPH) was upgraded by research analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a research report issued on Saturday.

  • [By Travis Hoium]

    A year ago, Enphase Energy (NASDAQ:ENPH) was on the brink of collapse. The company was reporting unsustainable losses and revenue was falling as competition in the module-level electronics business picked up.�

Hot High Tech Stocks To Invest In Right Now: VistaGen Therapeutics, Inc. (VTGN)

Advisors' Opinion:
  • [By Logan Wallace]

    Maxim Group assumed coverage on shares of Vistagen Therapeutics (NASDAQ:VTGN). The firm issued a buy rating on the stock.

    Sanford C. Bernstein assumed coverage on shares of Zimmer Biomet (NYSE:ZBH). Sanford C. Bernstein issued an underperform rating on the stock.

  • [By Shane Hupp]

    Vistagen Therapeutics Inc (NASDAQ:VTGN)’s share price gapped down before the market opened on Wednesday . The stock had previously closed at $1.11, but opened at $1.27. Vistagen Therapeutics shares last traded at $1.31, with a volume of 5600 shares changing hands.

  • [By Max Byerly]

    These are some of the media stories that may have effected Accern Sentiment Analysis’s scoring:

    Get Vistagen Therapeutics alerts: Investor’s Alert (Earnings Per Share) �� VistaGen Therapeutics Inc (NASDAQ: VTGN) (stocksmarketcap.com) Stock Technical’s & Performances to Explore �� VistaGen Therapeutics Inc (NASDAQ: VTGN) (stockspen.com) US STOCKS ON THE MOVE-Media and telecom stocks, H & R Block, TAL Education (nasdaq.com) Tracking the HMA Level on These Shares: VistaGen Therapeutics, Inc. (:VTGN): HMA Reading 1.4214792 (stocknewscaller.com) Keep Your Eyes on Hot Stock of Yesterday�� VistaGen Therapeutics, Inc. (VTGN) (stockmarketstop.com)

    Vistagen Therapeutics traded down $0.02, reaching $1.46, on Tuesday, according to MarketBeat Ratings. The company’s stock had a trading volume of 2,930 shares, compared to its average volume of 2,201,613. The stock has a market cap of $34.35 million, a P/E ratio of -0.95 and a beta of 0.29. Vistagen Therapeutics has a 52 week low of $0.69 and a 52 week high of $2.65.

  • [By Money Morning News Team]

    While exciting, CODX and our other penny stocks to watch this week are unlikely to tack on any additional gains this week. But don't worry. After looking at our 10 top penny stocks to watch, we'll show you a stock with serious profit potential in its future…

    Penny Stock Current Share Price Last Week's Gain Co-Diagnostics Inc. (Nasdaq: CODX) �$4.35 192.07% Viking Therapeutics Inc. (Nasdaq: VKTX) �$9.37 95.78% DHI Group Inc. (NYSE: DHX) �$3.10 67.57% Axovant Sciences Ltd. (Nasdaq: AXON) �$1.76 60.00% Netlist Inc. (Nasdaq: NLST) �$0.21 53.79% Link Motion Inc. (NYSE LKM) �$1.23 47.73% CorMedix Inc. (NYSE: CRMD) �$0.26 44.44% Vistagen Therapeutics Inc. (Nasdaq: VTGN) �$1.34 40.21% J. Jill Inc. (NYSE: JILL) �$8.30 36.55% Adomani Inc. (Nasdaq: ADOM) �$1.52 34.86%

    In order to make sure we protect ourselves from any substantial losses from investing in penny stocks, we follow five rules for penny stock investing. Take look at them on the right.As these stocks demonstrate, there are penny stocks that have tremendous growth potential that can easily dwarf your initial investment. However, most penny stocks lack the solid underlying financials necessary to generate a significant return.
    Fast Money: This powerful secret made one man a millionaire. Now he's sharing it live on camera – find out how you could use it to become $2,918 richer in less than a minute. Click here…

  • [By Money Morning News Team]

    Consider one of the top penny stocks from December,�VistaGen Therapeutics Inc.�(Nasdaq: VTGN). VTGN shares soared 156% in a single day of trading on Dec. 6.

Hot High Tech Stocks To Invest In Right Now: Ampio Pharmaceutical(AMPE)

Advisors' Opinion:
  • [By Ethan Ryder]

    Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) saw a large drop in short interest during the month of May. As of May 31st, there was short interest totalling 10,472,904 shares, a drop of 6.6% from the May 15th total of 11,209,042 shares. Based on an average daily trading volume, of 806,646 shares, the days-to-cover ratio is currently 13.0 days. Currently, 13.5% of the shares of the company are sold short.

Hot High Tech Stocks To Invest In Right Now: Illinois Tool Works Inc.(ITW)

Advisors' Opinion:
  • [By ]

    In the Lightning Round, Cramer was bullish on Idexx Laboratories (IDXX) , XPO Logistics (XPO) , Diamondback Energy (FANG) and Illinois Tool Works (ITW) .

  • [By ]

    Illinois Tools Works (ITW) shares fell after the company's earnings report, but Cramer and the AAP team see it as an opportunity to buy more shares. Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

  • [By ]

    Illinois Tool Works (ITW) : "You don't have to worry. This one is good. You shouldn't be a seller."

    PetMed Express (PETS) : "No, no, no, no. When we want pet drugs, we want Idexx Laboratories (IDXX) ."

  • [By ]

    Illinois Tools Works (ITW) shares fell after the company's earnings report, but Cramer and the AAP team see it as an opportunity to buy more shares. Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

Hot High Tech Stocks To Invest In Right Now: Kopin Corporation(KOPN)

Advisors' Opinion:
  • [By Joseph Griffin]

    Here are some of the news headlines that may have effected Accern’s rankings:

    Get Kopin alerts: Global Microdisplay Market Report 2018-2023 eMagin Corporation, Kopin Corporation, LG Display Co., Ltd., AU … (ittechnology24.com) Price Performance Review on Shares of Kopin Cp (KOPN): Move 3.12% (parkcitycaller.com) MAMA Cross Spotted in Kopin Cp (KOPN) Shares (fisherbusinessnews.com) Is Kopin Corporation (NasdaqGS:KOPN) Generating Enough Return on Equity? (derbynewsjournal.com) Hot Stocks- Vicon Industries, Inc. (NYSE:VII), Kopin Corporation (NASDAQ:KOPN), Mannatech, Incorporated (NASDAQ … (journalfinance.net)

    Shares of Kopin traded up $0.03, reaching $3.34, on Monday, Marketbeat Ratings reports. The stock had a trading volume of 101,064 shares, compared to its average volume of 263,988. Kopin has a fifty-two week low of $2.80 and a fifty-two week high of $4.60.

  • [By Stephan Byrd]

    Taiwan Semiconductor Mfg. (NYSE: TSM) and Kopin (NASDAQ:KOPN) are both computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, earnings, risk, valuation, analyst recommendations and institutional ownership.

  • [By Joseph Griffin]

    News articles about Kopin (NASDAQ:KOPN) have trended somewhat positive on Wednesday, according to Accern. The research firm scores the sentiment of press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Kopin earned a daily sentiment score of 0.11 on Accern’s scale. Accern also gave headlines about the company an impact score of 45.9996934088004 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Wednesday, July 4, 2018

Fitch warns President Trump��s trade fight could cost the world $2 trillion in global trade

Fitch Ratings on Tuesday warned that rising tensions between the U.S. and its trading partners could lead to new measures with a greater impact on global growth with as much as $2 trillion in global trade in jeopardy if President Donald Trump remains on a trade warpath.

��The U.S. investigation into auto tariffs, possible additional U.S. tariffs on Chinese imports, and the likely reactions of other countries and blocs, point to a potential serious escalation, albeit with an impact that falls short of across-the-board tariffs imposed on all major trade flows,�� Brian Coulton, chief economist at Fitch, said in a report.

Coulton noted that although the actions taken by the U.S. as well as China and the EU so far have been too muted to affect his outlook on global economic performance, further measures could herald a significant escalation in the war.

Possible future measures

Trump��s threat of an additional $200 billion tariff on Chinese imports is likely to result in Beijing slapping a comprehensive tariff on all U.S. goods and services worth up to $188 billion, according to the economist.

The Asian country could also introduce non-tariff trade barriers.

See: How will investors know if there��s a full-blown trade war?

��It remains to be seen whether U.S. announcements are simply negotiating positions that may be modified. But the detailed preparation of, and justification for, such measures and the possibility of instant and strong retaliation by trading partners present growing risks to trade,�� he said.

Trump in recent months has stepped up criticism of what he perceives as unfair trade practices by other countries and has threatened to penalize them unless they offer better terms for American exporters.

Fears about a toxic fight among major trading countries have weighed on U.S. stocks with the Dow Jones Industrial Average DJIA, -0.54% the S&P 500 SPX, -0.49% �and the Nasdaq COMP, -0.86% �all struggling to advance in recent sessions.

See: Stocks may still be underestimating the risk of a blowup in trade tensions

No one has been immune from Trump��s attacks, including close allies such as Canada and Mexico, signatories of the North American Free Trade Agreement.

��If tensions rise further, the U.S. hardens its stance and fully withdraws from Nafta��which is not our base case��this would magnify the impact. The imposition of high tariffs on U.S. auto imports would represent an existential threat to Nafta,�� said Coulton.

See: What��s next for Mexico and Nafta under President AMLO?

Aside from trillions in global trade, the economist expects a ��shock�� of 35% to 40% on U.S. import prices and about 0.5 percentage point negative impact on U.S.��s gross domestic product growth.

��A major global tariff shock would have adverse supply side impacts, raising costs for importers and disrupting supply-chains, while reducing consumers�� real wages. The global multiplier effect of lower U.S. imports could be significant. U.S. outward foreign direct investment��the largest source of FDI globally��would probably fall,�� said Coulton. ��Along with weaker confidence and lower investment, a global tariff shock

Sunday, June 24, 2018

$155.99 Million in Sales Expected for Scorpio Tankers Inc. (STNG) This Quarter

Brokerages expect Scorpio Tankers Inc. (NYSE:STNG) to announce sales of $155.99 million for the current quarter, Zacks Investment Research reports. Five analysts have provided estimates for Scorpio Tankers’ earnings, with the highest sales estimate coming in at $159.34 million and the lowest estimate coming in at $150.59 million. Scorpio Tankers reported sales of $118.42 million during the same quarter last year, which indicates a positive year over year growth rate of 31.7%. The business is scheduled to issue its next quarterly earnings results on Monday, September 17th.

On average, analysts expect that Scorpio Tankers will report full year sales of $678.08 million for the current fiscal year, with estimates ranging from $624.51 million to $723.00 million. For the next financial year, analysts expect that the business will report sales of $734.69 million per share, with estimates ranging from $656.72 million to $837.62 million. Zacks’ sales calculations are a mean average based on a survey of sell-side analysts that cover Scorpio Tankers.

Get Scorpio Tankers alerts:

Scorpio Tankers (NYSE:STNG) last announced its earnings results on Wednesday, April 25th. The shipping company reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.02). Scorpio Tankers had a negative return on equity of 7.61% and a negative net margin of 32.67%. The business had revenue of $156.50 million during the quarter, compared to analysts’ expectations of $154.72 million. During the same quarter in the previous year, the firm earned ($0.07) EPS. Scorpio Tankers’s quarterly revenue was up 27.4% on a year-over-year basis.

STNG has been the topic of a number of research analyst reports. Bank of America cut their target price on Scorpio Tankers from $3.85 to $2.75 and set a “buy” rating on the stock in a research note on Monday, March 19th. Zacks Investment Research upgraded Scorpio Tankers from a “sell” rating to a “hold” rating in a research note on Tuesday, April 3rd. Deutsche Bank restated a “buy” rating on shares of Scorpio Tankers in a research note on Tuesday, April 10th. DNB Markets upgraded Scorpio Tankers from a “hold” rating to a “buy” rating in a research note on Wednesday, April 25th. Finally, Morgan Stanley cut their target price on Scorpio Tankers from $3.50 to $3.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 25th. Two investment analysts have rated the stock with a sell rating, one has given a hold rating and eight have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus price target of $4.21.

Several large investors have recently bought and sold shares of the stock. Dimensional Fund Advisors LP raised its holdings in Scorpio Tankers by 14.4% during the 1st quarter. Dimensional Fund Advisors LP now owns 21,792,389 shares of the shipping company’s stock valued at $42,713,000 after acquiring an additional 2,743,205 shares during the period. Bank of New York Mellon Corp raised its holdings in Scorpio Tankers by 232.0% during the 4th quarter. Bank of New York Mellon Corp now owns 16,105,736 shares of the shipping company’s stock valued at $49,123,000 after acquiring an additional 11,255,133 shares during the period. BlackRock Inc. raised its holdings in Scorpio Tankers by 8.9% during the 1st quarter. BlackRock Inc. now owns 12,131,850 shares of the shipping company’s stock valued at $23,779,000 after acquiring an additional 993,468 shares during the period. Russell Investments Group Ltd. raised its holdings in Scorpio Tankers by 40.6% during the 1st quarter. Russell Investments Group Ltd. now owns 7,339,738 shares of the shipping company’s stock valued at $14,385,000 after acquiring an additional 2,121,265 shares during the period. Finally, Nuveen Asset Management LLC raised its holdings in Scorpio Tankers by 1.3% during the 1st quarter. Nuveen Asset Management LLC now owns 6,184,122 shares of the shipping company’s stock valued at $12,121,000 after acquiring an additional 80,911 shares during the period. 57.04% of the stock is currently owned by institutional investors.

Shares of NYSE STNG traded up $0.13 during midday trading on Friday, reaching $3.03. The company’s stock had a trading volume of 9,255,893 shares, compared to its average volume of 4,591,684. Scorpio Tankers has a 12-month low of $1.85 and a 12-month high of $4.20. The company has a market capitalization of $961.73 million, a PE ratio of -6.45 and a beta of 1.34. The company has a quick ratio of 1.05, a current ratio of 1.09 and a debt-to-equity ratio of 1.55.

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 28th. Investors of record on Wednesday, June 6th will be issued a $0.01 dividend. The ex-dividend date is Tuesday, June 5th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 1.32%. Scorpio Tankers’s dividend payout ratio (DPR) is presently -8.51%.

Scorpio Tankers Company Profile

Scorpio Tankers Inc, together with its subsidiaries, engages in the seaborne transportation of refined petroleum products worldwide. As of March 22, 2018, its fleet consisted of 109 tankers, including 38 LR2, 12 LR1, 45 MR, and 14 Handymax tankers with an average age of approximately 2.6 years; and 20 time or bareboat chartered-in tankers, which include 2 LR2, 10 MR, and 8 Handymax tankers.

Get a free copy of the Zacks research report on Scorpio Tankers (STNG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Scorpio Tankers (NYSE:STNG)

Tuesday, May 29, 2018

-$0.07 Earnings Per Share Expected for CryoPort Inc (CYRX) This Quarter

Analysts forecast that CryoPort Inc (NASDAQ:CYRX) will post ($0.07) earnings per share for the current fiscal quarter, Zacks reports. Three analysts have made estimates for CryoPort’s earnings, with the lowest EPS estimate coming in at ($0.08) and the highest estimate coming in at ($0.07). CryoPort posted earnings per share of ($0.08) during the same quarter last year, which indicates a positive year over year growth rate of 12.5%. The firm is expected to report its next earnings results on Tuesday, August 14th.

According to Zacks, analysts expect that CryoPort will report full-year earnings of ($0.29) per share for the current year, with EPS estimates ranging from ($0.31) to ($0.27). For the next fiscal year, analysts forecast that the firm will post earnings of $0.01 per share, with EPS estimates ranging from ($0.13) to $0.24. Zacks’ earnings per share calculations are a mean average based on a survey of analysts that follow CryoPort.

Get CryoPort alerts:

CryoPort (NASDAQ:CYRX) last announced its earnings results on Thursday, May 3rd. The consumer goods maker reported ($0.10) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.07) by ($0.03). The business had revenue of $4.02 million for the quarter, compared to analyst estimates of $3.84 million. CryoPort had a negative return on equity of 48.12% and a negative net margin of 66.29%. The company’s quarterly revenue was up 48.3% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.10) earnings per share.

Several brokerages have recently weighed in on CYRX. BidaskClub raised CryoPort from a “hold” rating to a “buy” rating in a research note on Monday, May 14th. ValuEngine raised CryoPort from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, May 2nd. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $11.00 target price (up from $10.00) on shares of CryoPort in a research note on Thursday, March 8th. Five analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $11.63.

In related news, CEO Jerrell Shelton sold 29,257 shares of the stock in a transaction on Tuesday, March 13th. The stock was sold at an average price of $9.83, for a total value of $287,596.31. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 9.60% of the stock is currently owned by corporate insiders.

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Creative Planning acquired a new position in CryoPort in the 4th quarter valued at $5,176,000. Millennium Management LLC raised its stake in CryoPort by 205.0% in the 1st quarter. Millennium Management LLC now owns 434,068 shares of the consumer goods maker’s stock valued at $3,733,000 after purchasing an additional 291,737 shares during the last quarter. Taylor Wealth Management Partners raised its stake in CryoPort by 5.6% in the 4th quarter. Taylor Wealth Management Partners now owns 415,575 shares of the consumer goods maker’s stock valued at $3,570,000 after purchasing an additional 21,935 shares during the last quarter. OppenheimerFunds Inc. raised its stake in CryoPort by 20.6% in the 4th quarter. OppenheimerFunds Inc. now owns 406,829 shares of the consumer goods maker’s stock valued at $3,495,000 after purchasing an additional 69,571 shares during the last quarter. Finally, Allianz Asset Management GmbH raised its stake in CryoPort by 240.5% in the 4th quarter. Allianz Asset Management GmbH now owns 387,099 shares of the consumer goods maker’s stock valued at $3,325,000 after purchasing an additional 273,426 shares during the last quarter. 28.67% of the stock is owned by hedge funds and other institutional investors.

Shares of CryoPort traded up $1.19, hitting $12.02, during trading hours on Friday, Marketbeat Ratings reports. 1,160,486 shares of the company’s stock were exchanged, compared to its average volume of 224,674. The company has a market cap of $330.73 million, a price-to-earnings ratio of -35.35 and a beta of 0.71. CryoPort has a fifty-two week low of $3.08 and a fifty-two week high of $12.08.

CryoPort Company Profile

Cryoport, Inc provides cryogenic logistics solutions to the life sciences industry in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, a dry vapor cryogenic shipper that use liquid nitrogen contained inside a vacuum insulated vessel, which serves as a refrigerant to provide stable storage temperatures.

Get a free copy of the Zacks research report on CryoPort (CYRX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for CryoPort (NASDAQ:CYRX)

Monday, May 28, 2018

Abiomed (ABMD) Sets New 12-Month High and Low at $403.44

Abiomed (NASDAQ:ABMD) shares reached a new 52-week high and low during mid-day trading on Thursday . The stock traded as low as $403.44 and last traded at $395.54, with a volume of 13610 shares. The stock had previously closed at $395.52.

Several research analysts have recently issued reports on the company. Piper Jaffray Companies upped their price objective on Abiomed to $360.00 and gave the stock an “overweight” rating in a research report on Thursday, May 3rd. ValuEngine raised Abiomed from a “buy” rating to a “strong-buy” rating in a research report on Thursday, May 3rd. Zacks Investment Research raised Abiomed from a “hold” rating to a “buy” rating and set a $338.00 price objective for the company in a research report on Thursday, May 3rd. Morgan Stanley upped their price objective on Abiomed from $259.00 to $320.00 and gave the stock an “equal weight” rating in a research report on Tuesday, May 1st. Finally, Goldman Sachs Group assumed coverage on Abiomed in a research report on Wednesday, April 4th. They set a “buy” rating and a $332.00 price objective for the company. Two analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the stock. Abiomed currently has an average rating of “Buy” and a consensus price target of $325.00.

Get Abiomed alerts:

The stock has a market capitalization of $17.47 billion, a PE ratio of 165.05, a PEG ratio of 4.26 and a beta of 0.18.

Abiomed (NASDAQ:ABMD) last announced its earnings results on Thursday, May 3rd. The medical equipment provider reported $0.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.64 by $0.16. The firm had revenue of $174.44 million during the quarter, compared to analysts’ expectations of $164.30 million. Abiomed had a return on equity of 17.58% and a net margin of 18.89%. The business’s revenue was up 39.9% on a year-over-year basis. During the same period in the prior year, the firm earned $0.33 EPS. equities research analysts predict that Abiomed will post 3.43 EPS for the current fiscal year.

In related news, Director Martin P. Sutter sold 21,890 shares of the company’s stock in a transaction dated Tuesday, May 8th. The stock was sold at an average price of $343.50, for a total value of $7,519,215.00. Following the completion of the sale, the director now directly owns 46,668 shares of the company’s stock, valued at approximately $16,030,458. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, SVP William J. Bolt sold 22,790 shares of the company’s stock in a transaction dated Monday, May 7th. The shares were sold at an average price of $348.03, for a total value of $7,931,603.70. Following the completion of the sale, the senior vice president now directly owns 66,414 shares of the company’s stock, valued at $23,114,064.42. The disclosure for this sale can be found here. Over the last three months, insiders sold 62,180 shares of company stock valued at $21,542,744. Insiders own 7.00% of the company’s stock.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Harvest Fund Management Co. Ltd purchased a new stake in Abiomed during the 1st quarter valued at approximately $108,000. Dupont Capital Management Corp purchased a new stake in Abiomed during the 1st quarter valued at approximately $161,000. Cerebellum GP LLC purchased a new stake in Abiomed during the 4th quarter valued at approximately $127,000. Mutual Advisors LLC purchased a new stake in Abiomed during the 1st quarter valued at approximately $206,000. Finally, Intersect Capital LLC purchased a new stake in Abiomed during the 1st quarter valued at approximately $214,000. 87.79% of the stock is owned by hedge funds and other institutional investors.

Abiomed Company Profile

ABIOMED, Inc engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides continuum of care to heart failure patients. The company offers Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; Impella CP that provides partial circulatory support using an extracorporeal bypass control unit; Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; and Impella RP, a percutaneous catheter-based axial flow pump.

Saturday, May 26, 2018

Teacher Retirement System of Texas Lowers Holdings in Sempra Energy (SRE)

Teacher Retirement System of Texas lowered its position in shares of Sempra Energy (NYSE:SRE) by 19.2% in the first quarter, HoldingsChannel.com reports. The fund owned 52,783 shares of the utilities provider’s stock after selling 12,538 shares during the quarter. Teacher Retirement System of Texas’ holdings in Sempra Energy were worth $5,871,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently modified their holdings of SRE. Pin Oak Investment Advisors Inc. acquired a new stake in Sempra Energy during the 4th quarter worth about $116,000. Front Row Advisors LLC acquired a new stake in Sempra Energy during the 4th quarter worth about $130,000. Calton & Associates Inc. acquired a new stake in Sempra Energy during the 4th quarter worth about $139,000. Focused Wealth Management Inc acquired a new stake in Sempra Energy during the 4th quarter worth about $160,000. Finally, Sequoia Wealth Management LLC acquired a new stake in Sempra Energy during the 4th quarter worth about $200,000. 90.15% of the stock is owned by institutional investors.

Get Sempra Energy alerts:

NYSE SRE opened at $105.21 on Friday. The stock has a market cap of $27.70 billion, a price-to-earnings ratio of 19.41, a P/E/G ratio of 2.16 and a beta of 0.48. Sempra Energy has a fifty-two week low of $100.63 and a fifty-two week high of $122.97. The company has a quick ratio of 0.34, a current ratio of 0.37 and a debt-to-equity ratio of 1.26.

Sempra Energy (NYSE:SRE) last released its quarterly earnings data on Monday, May 7th. The utilities provider reported $1.43 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.62 by ($0.19). The company had revenue of $2.96 billion for the quarter, compared to analysts’ expectations of $3.28 billion. Sempra Energy had a net margin of 1.45% and a return on equity of 8.30%. The business’s quarterly revenue was down 2.3% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.74 EPS. analysts forecast that Sempra Energy will post 5.48 EPS for the current year.

In related news, Chairman Debra L. Reed sold 49,909 shares of Sempra Energy stock in a transaction dated Thursday, April 5th. The stock was sold at an average price of $110.37, for a total value of $5,508,456.33. Following the completion of the transaction, the chairman now owns 177,227 shares in the company, valued at approximately $19,560,543.99. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, VP G Joyce Rowland sold 3,948 shares of Sempra Energy stock in a transaction dated Thursday, April 5th. The shares were sold at an average price of $109.81, for a total value of $433,529.88. Following the completion of the transaction, the vice president now owns 2,655 shares of the company’s stock, valued at approximately $291,545.55. The disclosure for this sale can be found here. Insiders have sold a total of 55,775 shares of company stock valued at $6,142,993 in the last quarter. Company insiders own 0.17% of the company’s stock.

SRE has been the subject of a number of research reports. Zacks Investment Research raised Sempra Energy from a “hold” rating to a “buy” rating and set a $125.00 price target for the company in a research report on Wednesday, March 28th. TheStreet cut Sempra Energy from a “b-” rating to a “c” rating in a research report on Tuesday, February 27th. UBS initiated coverage on Sempra Energy in a research report on Friday, February 2nd. They set a “buy” rating and a $124.00 price target for the company. Wells Fargo & Co reaffirmed a “buy” rating and set a $120.00 price target (down previously from $121.00) on shares of Sempra Energy in a research report on Wednesday, February 28th. Finally, Scotiabank raised Sempra Energy from a “sector perform” rating to an “outperform” rating in a research report on Thursday, April 26th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and nine have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of $120.64.

Sempra Energy Company Profile

Sempra Energy, together with its subsidiaries, invests in, develops, and operates energy infrastructure, as well as provides electric and gas services in the United States and internationally. The company's San Diego Gas & Electric Company segment engages in the generation, transmission, and distribution of electricity.

Want to see what other hedge funds are holding SRE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sempra Energy (NYSE:SRE).

Institutional Ownership by Quarter for Sempra Energy (NYSE:SRE)

Friday, May 25, 2018

Head-To-Head Survey: Pulmatrix (PULM) versus The Competition

Pulmatrix (NASDAQ: PULM) is one of 491 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its rivals? We will compare Pulmatrix to related businesses based on the strength of its earnings, analyst recommendations, profitability, risk, institutional ownership, valuation and dividends.

Volatility & Risk

Get Pulmatrix alerts:

Pulmatrix has a beta of 2.74, meaning that its share price is 174% more volatile than the S&P 500. Comparatively, Pulmatrix’s rivals have a beta of 1.09, meaning that their average share price is 9% more volatile than the S&P 500.

Valuation and Earnings

This table compares Pulmatrix and its rivals top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Pulmatrix $340,000.00 -$18.05 million -0.48
Pulmatrix Competitors $2.01 billion $135.87 million -3.38

Pulmatrix’s rivals have higher revenue and earnings than Pulmatrix. Pulmatrix is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares Pulmatrix and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Pulmatrix N/A -171.39% -109.20%
Pulmatrix Competitors -2,958.10% -158.97% -30.57%

Insider and Institutional Ownership

18.6% of Pulmatrix shares are owned by institutional investors. Comparatively, 47.5% of shares of all “Pharmaceutical preparations” companies are owned by institutional investors. 26.0% of Pulmatrix shares are owned by company insiders. Comparatively, 15.6% of shares of all “Pharmaceutical preparations” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Analyst Ratings

This is a breakdown of recent recommendations for Pulmatrix and its rivals, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pulmatrix 0 0 2 0 3.00
Pulmatrix Competitors 2998 9071 22008 625 2.58

Pulmatrix currently has a consensus price target of $3.00, indicating a potential upside of 569.79%. As a group, “Pharmaceutical preparations” companies have a potential upside of 42.33%. Given Pulmatrix’s stronger consensus rating and higher possible upside, equities research analysts plainly believe Pulmatrix is more favorable than its rivals.

Summary

Pulmatrix beats its rivals on 7 of the 13 factors compared.

Pulmatrix Company Profile

Pulmatrix, Inc., a clinical stage biopharmaceutical company, develops inhaled therapies to address serious pulmonary diseases using its inhaled Small Particles Easily Respirable and Emitted (iSPERSE) technology. Its proprietary product pipeline focuses on advancing treatments for serious lung diseases, including Pulmazole, an inhaled anti-fungal for patients with allergic bronchopulmonary aspergillosis; and PUR1800, kinase inhibitor for patients with obstructive lung diseases, including asthma and chronic obstructive pulmonary disease (COPD). The company is also involved in developing PUR0200, a reformulation of an existing long-acting antimuscarinic agent that has completed Phase Ib clinical development, which blocks the effects of acetylcholine on muscarinic receptors to reverse airway obstruction in COPD patients. It has a license agreement with RespiVert Ltd. to develop kinase inhibitor for access to a portfolio of novel drug candidates; and a partnership agreement with Vectura Group plc to develop its drug candidate. Pulmatrix, Inc. was founded in 2003 and is headquartered in Lexington, Massachusetts.

Thursday, May 24, 2018

Hot Gold Stocks For 2019

tags:SUN,PPP,HST,ADX,

The fear over 10-year U.S. Treasury yields breaking through 3 percent has been a long time coming, according to Societe Generale SA.

“Interest rates are already doing damage, people just haven’t noticed,” Andrew Lapthorne, the firm’s global head of quantitative strategy, said in an interview Tuesday. “Leverage in the U.S. is grotesque for this stage of the cycle. At the moment you’ve got peak leverage at peak prices. It’s not like you have to dig deep to find a problem.”

The number-one conversation Societe Generale’s having with clients right now is about the correlation between bonds and equities. But risks to corporate balance sheets is a bigger problem at the moment, particularly in the U.S. and China. Lapthorne said he worries about volatility in debt because of the impact it can have on the economy, particularly how it weighs on businesses and the job market.

#lazy-img-327023302:before{padding-top:49.66666666666666%;}

Credit markets may get choppier due to triggers like high-profile bankruptcies, such as Toys ‘R’ Us, or if corporate buybacks drop, Lapthorne said. While Credit Suisse anticipates fewer share repurchases this year, they’re an outlier. JPMorgan Chase & Co. estimates they’ll rise to a record $800 billion from $530 billion last year. Bank of America Corp. said if the current pace continues there may be as much as $850 billion in 2018, while Goldman Sachs Group Inc. sees buybacks becoming “less constructive” in 2019.

Hot Gold Stocks For 2019: Sunoco LP(SUN)

Advisors' Opinion:
  • [By Stephan Byrd]

    Sunoco (NYSE: SUN) and Macquarie Infrastructure (NYSE:MIC) are both mid-cap oils/energy companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, profitability, dividends, analyst recommendations, valuation and institutional ownership.

  • [By Benzinga News Desk]

    President Donald Trump hinted he may intervene in the Justice Department’s Russia investigation, as a Senate panel advanced a measure to protect Special Counsel Robert Mueller: Link

    ECONOMIC DATA USA GDP (QoQ) for Q1 2.30% vs 2.00% Est; Prior 2.90% The University of Michigan's consumer confidence index for April is schedule for release at 10:00 a.m. ET. The Baker Hughes North American rig count report for the latest week will be released at 1:00 p.m. ET. Data on farm prices for the recent week will be released at 3:00 p.m. ET. ANALYST RATINGS Stifel upgraded Facebook (NASDAQ: FB) from Hold to Buy Morgan Stanley upgraded Acacia Communications (NASDAQ: ACIA) from Underweight to Equal-Weight Jefferies downgraded Sunoco (NYSE: SUN) from Hold to Underperform KBW downgraded Oaktree Capital (NYSE: OAK) from Outperform to Market Perform

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.

  • [By Matthew DiLallo]

    The only segment where earnings declined was the catch-all one labeled "all other," which houses different investments such as its stake in Sunoco L.P. (NYSE:SUN) and PES, a refining joint venture. PES has struggled due to higher costs, and recently declared bankruptcy. Meanwhile, Energy Transfer's earnings from Sunoco L.P. declined because that entity sold the bulk of its retail assets and then used that cash to repurchase a portion of Energy Transfer's investment.

  • [By Joseph Griffin]

    Sunoco (NYSE:SUN) released its quarterly earnings results on Wednesday. The oil and gas company reported ($3.74) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.57 by ($4.31), Briefing.com reports. Sunoco had a return on equity of 17.06% and a net margin of 1.27%. The firm had revenue of $3.75 billion for the quarter, compared to the consensus estimate of $3 billion. During the same quarter in the previous year, the business posted ($0.22) EPS. The firm’s revenue for the quarter was up 33.5% compared to the same quarter last year.

  • [By Matthew DiLallo]

    However, he did rule out the possibility that the company would also roll up its other MLP Sunoco LP (NYSE:SUN). He said that "we're very pleased with what we're seeing at SUN as far as the growth that they will be directing that MLP into. And as you know, SUN is younger in the IDR life." Because of that "for the reasonable future, we don't see that being rolled up."

  • [By ]

    That's the case for Sunoco (NYSE: SUN). After posting a net loss of $0.09 per share in 2017, the gas station owner is expected to swing to a hefty profit of $2.35 per share in 2018. But of the 14 analysts who follow the company, earnings estimates range as low as $1.22 and as high as $3.35 -- so there is a high degree of uncertainty.�

Hot Gold Stocks For 2019: Primero Mining Corp(PPP)

Advisors' Opinion:
  • [By Logan Wallace]

    PayPie (CURRENCY:PPP) traded 0.5% lower against the U.S. dollar during the 24 hour period ending at 17:00 PM ET on May 18th. One PayPie token can now be bought for $0.71 or 0.00008653 BTC on cryptocurrency exchanges including EtherDelta (ForkDelta) and Fatbtc. During the last week, PayPie has traded 8.5% lower against the U.S. dollar. PayPie has a market capitalization of $58.95 million and approximately $821,053.00 worth of PayPie was traded on exchanges in the last 24 hours.

Hot Gold Stocks For 2019: Host Hotels & Resorts, Inc.(HST)

Advisors' Opinion:
  • [By ]

    Selected examples: (BXP) , (DFS) , (HST) , (MA) , (TXN) , (USB) .

    Inflation Is a Key Risk

    Execs were most worried about inflation, as they should be.

  • [By Max Byerly]

    ING Groep NV increased its stake in shares of Host Hotels & Resorts (NYSE:HST) by 6.6% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 75,007 shares of the real estate investment trust’s stock after buying an additional 4,642 shares during the quarter. ING Groep NV’s holdings in Host Hotels & Resorts were worth $1,398,000 at the end of the most recent reporting period.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Host Hotels & Resorts (HST)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Host Hotels & Resorts (NYSE:HST) had its price objective boosted by Stifel Nicolaus from $20.50 to $21.00 in a research note published on Thursday. They currently have a buy rating on the real estate investment trust’s stock.

Hot Gold Stocks For 2019: Adams Diversified Equity Fund, Inc.(ADX)

Advisors' Opinion:
  • [By Shane Hupp]

    AdEx (CURRENCY:ADX) traded 2.3% lower against the U.S. dollar during the 1-day period ending at 15:00 PM E.T. on May 12th. One AdEx token can now be purchased for $0.77 or 0.00009068 BTC on major cryptocurrency exchanges including IDEX, EtherDelta (ForkDelta), Binance and Gatecoin. During the last seven days, AdEx has traded 25.9% lower against the U.S. dollar. AdEx has a total market cap of $56.24 million and $2.87 million worth of AdEx was traded on exchanges in the last day.

  • [By Max Byerly]

    AdEx (CURRENCY:ADX) traded up 9.2% against the dollar during the twenty-four hour period ending at 18:00 PM Eastern on April 24th. In the last seven days, AdEx has traded up 47.7% against the dollar. One AdEx token can now be purchased for about $1.12 or 0.00011782 BTC on major cryptocurrency exchanges including IDEX, Huobi, EtherDelta (ForkDelta) and Liqui. AdEx has a total market cap of $81.99 million and approximately $13.84 million worth of AdEx was traded on exchanges in the last day.

Tuesday, May 22, 2018

Hot Low Price Stocks To Buy For 2018

tags:WWW,ARCW,GCAP,EQS,TXMD,DECK,

There are numerous trading techniques to consider for each and every options trade, so Fred Oltarsh at Options Strategy Network details five of the ones he considers extremely vital for trying to put the percentages in the trader's favor.

The key to trading options contracts successfully (individual stocks and futures as well) is to put the percentages in your favor. This involves numerous trading techniques discussed in the Options Strategy Network options guide. Briefly, one should consider the following factors for each and every trade: 1) liquidity or the cost to initiate and liquidate the position, 2) implied volatility or the relative value of the particular option one is trading, 3) having a pre-designated point of liquidation, 4) risk/reward ratio after commissions and slippage and 5) diversification of strategies and trades.

Each analysis described above increases the likelihood of success of an individual trade. Examining the liquidity of the market that one is about to trade is the first step to increasing levels of productivity. If one is buying a stock for a long-term hold, the implications of liquidity are not as great for that trader as for the trader who intends to buy and sell stock frequently. If one is day trading, whether stocks or options, even a bid/ask spread of a penny on a low priced stock, has an impact on the bottom line. The best way to analyze it is to quickly determine the difference of the bid/ask spread as a percentage of the value of the instrument traded. Then determine what that value is per one thousand dollars invested. If the number sounds high, it's probably worth staying away from that trade.

Hot Low Price Stocks To Buy For 2018: Wolverine World Wide, Inc.(WWW)

Advisors' Opinion:
  • [By Garrett Baldwin]

    While that is happening in the Middle East, trouble is brewing in Washington. In addition to reports that a Russian Oligarch paid Trump's lawyer $500,000, a U.S. telecom giant is now caught up with the same lawyer. AT&T Corporation (NYSE: T) confirmed Tuesday night that it paid Trump lawyer Michael Cohen for information on the administration. AT&T stock is up 0.6% in premarket hours. Four Stocks to Watch Today: TRIP, MTCH, FOXA, DIS Shares of TripAdvisor (Nasdaq: TRIP) popped nearly 20% after the company crushed earnings after the bell. In addition, the CFO Ernst Teunissen projected strong guidance for the rest of the year. The firm reported EPS of $0.30 on top of $378.0 million in revenue. Wall Street expected $0.16 per share on $360.84 million in revenue. Shares of Match Group (Nasdaq: MTCH) popped 3% after the company reported earnings after the bell. The dating site operator reported stronger than expected earnings and revenue figures on Tuesday. Overall, revenue jumped 36% compared to the same period in 2017. The firm also reported stronger than expected guidance. Of course, all anyone is talking about how Facebook Inc. (Nasdaq: FB) could impact the dating industry with its new plugin. Shares of 21st Century Fox (NYSE FOXA) are in focus as the firm prepares to report earnings before the bell. However, investors are more likely focused today on the expected bidding war between the Walt Disney Co. (NYSE: DIS) and Comcast Corporation (Nasdaq: CMCSA) to purchase key assets of the company. Fox is also tied up in a bidding war with Comcast to purchase British television provider Sky (OTC MKTS: SKYAY). Look for additional earnings reports from Booking Holdings (Nasdaq: BKNG), com International (Nasdaq: CTRP), Sina Corp. (Nasdaq: SINA), Albermarle Corp. (NYSE: ALB), Mylan Inc. (NYSE: MYL), SolarEdge Technologies (Nasdaq: SEDG), Wolverine World Wide (NYSE: WWW), IAC Interactive Corp. (NYSE: IAC), and Cavium Inc. (Nasdaq: CAVM).

    Eight Seconds

  • [By Ethan Ryder]

    Wolverine World Wide (NYSE:WWW)’s share price gapped up prior to trading on Thursday following a better than expected earnings announcement. The stock had previously closed at $33.18, but opened at $32.32. Wolverine World Wide shares last traded at $31.45, with a volume of 29527 shares changing hands.

  • [By Stephan Byrd]

    Wolverine World Wide (NYSE:WWW)‘s stock had its “neutral” rating restated by Buckingham Research in a research note issued to investors on Wednesday. They currently have a $32.00 target price on the textile maker’s stock. Buckingham Research’s target price would indicate a potential upside of 5.51% from the company’s current price.

  • [By Lisa Levin]

    Analysts at Susquehanna upgraded Wolverine World Wide, Inc. (NYSE: WWW) from Negative to Neutral.

    Wolverine shares rose 7.21 percent to close at $31.95 on Wednesday.

  • [By Lisa Levin] Companies Reporting Before The Bell Anheuser-Busch InBev SA/NV (NYSE: BUD) is estimated to report quarterly earnings at $0.89 per share on revenue of $13.06 billion. SINA Corporation (NASDAQ: SINA) is expected to report quarterly earnings at $0.42 per share on revenue of $433.32 million. Weibo Corporation (NASDAQ: WB) is projected to report quarterly earnings at $0.47 per share on revenue of $342.39 million. Ameren Corporation (NYSE: AEE) is estimated to report quarterly earnings at $0.57 per share on revenue of $1.55 billion. Mylan N.V. (NASDAQ: MYL) is projected to report quarterly earnings at $0.98 per share on revenue of $2.75 billion. Cinemark Holdings, Inc. (NYSE: CNK) is estimated to report quarterly earnings at $1.31 per share on revenue of $1.51 billion. ADT Inc. (NYSE: ADT) is expected to report quarterly earnings at $0.24 per share on revenue of $1.11 billion. Coty Inc. (NYSE: COTY) is projected to report quarterly earnings at $0.13 per share on revenue of $2.18 billion. Pinnacle Entertainment, Inc. (NYSE: PNK) is estimated to report quarterly earnings at $0.31 per share on revenue of $644.94 million. Conduent Incorporated (NYSE: CNDT) is estimated to report quarterly earnings at $0.21 per share on revenue of $1.44 billion. Delphi Technologies PLC (NYSE: DLPH) is projected to report quarterly earnings at $1.16 per share on revenue of $1.25 billion. Office Depot, Inc. (NASDAQ: ODP) is expected to report quarterly earnings at $0.08 per share on revenue of $2.72 billion. Global Partners LP (NYSE: GLP) is estimated to report quarterly earnings at $0.13 per share on revenue of $2.33 billion. Wolverine World Wide, Inc. (NYSE: WWW) is projected to report quarterly earnings at $0.37 per share on revenue of $530.99 million. Performance Food Group Company (NYSE: PFGC) is expected to report quarterly earnings at $0.32 per share on revenue of $4.46 billion. Groupon, Inc. (NASDAQ: GRPN) is projected to report

Hot Low Price Stocks To Buy For 2018: Arc Wireless Solutions Inc.(ARCW)

Advisors' Opinion:
  • [By Ethan Ryder]

    Watts Water Technologies (NYSE: WTS) and ARC Group WorldWide (NASDAQ:ARCW) are both computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations.

Hot Low Price Stocks To Buy For 2018: GAIN Capital Holdings, Inc.(GCAP)

Advisors' Opinion:
  • [By Joseph Griffin]

    GAIN Capital (NYSE:GCAP) insider Samantha Roady sold 4,826 shares of GAIN Capital stock in a transaction on Monday, May 7th. The stock was sold at an average price of $8.23, for a total transaction of $39,717.98. Following the completion of the transaction, the insider now owns 221,191 shares in the company, valued at approximately $1,820,401.93. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

  • [By Ethan Ryder]

    LSV Asset Management decreased its position in GAIN Capital (NYSE:GCAP) by 3.1% in the 1st quarter, HoldingsChannel reports. The fund owned 410,684 shares of the financial services provider’s stock after selling 13,200 shares during the period. LSV Asset Management’s holdings in GAIN Capital were worth $2,772,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Joseph Griffin]

    GAIN Capital (NYSE:GCAP) General Counsel Diego Rotsztain sold 3,184 shares of the company’s stock in a transaction on Monday, May 7th. The shares were sold at an average price of $8.23, for a total value of $26,204.32. Following the completion of the transaction, the general counsel now directly owns 98,663 shares in the company, valued at approximately $811,996.49. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Hot Low Price Stocks To Buy For 2018: Equus Total Return, Inc.(EQS)

Advisors' Opinion:
  • [By Anders Melin]

    Taking that a step further, you can run searches on the Equity Screening (EQS) function using the new pay metrics or data on say-on-pay, which refers to shareholders’ right to vote on management remuneration. To see Russell 1000 companies with the lowest support on pay, for example, go to {EQS <GO>}. In the Add Criteria field, enter RIY and click on the Russell 1000 Index match. Next, enter Say on Pay, click on the Say on Pay Support Level item, and press <GO>. Click on the See Results | WATC button for a list of companies in the benchmark that you can sort by the percentage of shareholders supporting management on pay.

Hot Low Price Stocks To Buy For 2018: TherapeuticsMD, Inc.(TXMD)

Advisors' Opinion:
  • [By ]

    TherapeuticsMD (Nasdaq: TXMD) is a pharmaceutical company with an exclusive focus on products for women and advanced hormone therapies. Biotech stocks are often a target for short sellers because of the uncertainty around drug development and approvals.

  • [By Ethan Ryder]

    TherapeuticsMD Inc (NASDAQ:TXMD)’s share price was up 6.4% on Friday . The stock traded as high as $6.07 and last traded at $6.02. Approximately 2,747,655 shares were traded during mid-day trading, an increase of 38% from the average daily volume of 1,984,159 shares. The stock had previously closed at $5.66.

  • [By Stephan Byrd]

    TherapeuticsMD Inc (NASDAQ:TXMD) was down 5% on Tuesday . The company traded as low as $5.80 and last traded at $5.85. Approximately 3,392,267 shares changed hands during trading, an increase of 65% from the average daily volume of 2,057,881 shares. The stock had previously closed at $6.16.

Hot Low Price Stocks To Buy For 2018: Deckers Outdoor Corporation(DECK)

Advisors' Opinion:
  • [By Max Byerly]

    Deckers Outdoor (NYSE: DECK) and Nike (NYSE:NKE) are both consumer discretionary companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, earnings, dividends, risk and valuation.

  • [By ]

    That tendency for more of the same is likely to be true for many companies, as well. Among the companies that are likely to continue with business as usual -- at least in the short term -- is Deckers Outdoor (NYSE: DECK).�

  • [By ]

    The great trading opportunity we looked at is in Deckers Outdoor (NYSE: DECK). The stock is on a "buy" signal, according to my award-winning ITV indicator.

Monday, May 21, 2018

Dupont Capital Management Corp Has $1.58 Million Holdings in Wells Fargo (WFC)

Dupont Capital Management Corp trimmed its position in shares of Wells Fargo (NYSE:WFC) by 84.4% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 30,092 shares of the financial services provider’s stock after selling 163,405 shares during the period. Dupont Capital Management Corp’s holdings in Wells Fargo were worth $1,577,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the business. Geode Capital Management LLC boosted its stake in Wells Fargo by 1.3% during the 4th quarter. Geode Capital Management LLC now owns 46,311,774 shares of the financial services provider’s stock valued at $2,803,705,000 after purchasing an additional 584,764 shares during the period. Dimensional Fund Advisors LP boosted its stake in Wells Fargo by 17.8% during the 3rd quarter. Dimensional Fund Advisors LP now owns 35,143,414 shares of the financial services provider’s stock valued at $1,937,888,000 after purchasing an additional 5,305,125 shares during the period. Davis Selected Advisers boosted its stake in Wells Fargo by 1.4% during the 3rd quarter. Davis Selected Advisers now owns 26,335,478 shares of the financial services provider’s stock valued at $1,451,064,000 after purchasing an additional 368,667 shares during the period. Magellan Asset Management Ltd boosted its stake in Wells Fargo by 5.1% during the 4th quarter. Magellan Asset Management Ltd now owns 25,007,676 shares of the financial services provider’s stock valued at $1,517,216,000 after purchasing an additional 1,222,262 shares during the period. Finally, Legal & General Group Plc boosted its stake in Wells Fargo by 3.1% during the 3rd quarter. Legal & General Group Plc now owns 23,220,873 shares of the financial services provider’s stock valued at $1,280,531,000 after purchasing an additional 696,233 shares during the period. 76.79% of the stock is owned by hedge funds and other institutional investors.

Get Wells Fargo alerts:

Wells Fargo opened at $53.70 on Monday, according to Marketbeat. The company has a debt-to-equity ratio of 1.27, a quick ratio of 0.86 and a current ratio of 0.88. Wells Fargo has a 12 month low of $49.27 and a 12 month high of $66.31. The company has a market capitalization of $261.94 billion, a P/E ratio of 13.07, a price-to-earnings-growth ratio of 1.45 and a beta of 1.13.

Wells Fargo (NYSE:WFC) last released its earnings results on Friday, April 13th. The financial services provider reported $1.12 EPS for the quarter, topping analysts’ consensus estimates of $1.07 by $0.05. Wells Fargo had a net margin of 22.80% and a return on equity of 12.46%. The business had revenue of $21.93 billion for the quarter, compared to the consensus estimate of $21.74 billion. During the same period in the previous year, the firm earned $1.00 EPS. The business’s revenue for the quarter was down 1.4% on a year-over-year basis. research analysts expect that Wells Fargo will post 4.57 EPS for the current fiscal year.

Wells Fargo announced that its board has approved a share repurchase program on Tuesday, January 23rd that allows the company to repurchase 350,000,000 outstanding shares. This repurchase authorization allows the financial services provider to purchase shares of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s board of directors believes its shares are undervalued.

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 1st. Investors of record on Friday, May 4th will be issued a $0.39 dividend. The ex-dividend date of this dividend is Thursday, May 3rd. This represents a $1.56 dividend on an annualized basis and a dividend yield of 2.91%. Wells Fargo’s payout ratio is currently 37.96%.

A number of analysts have commented on WFC shares. Morgan Stanley boosted their price target on shares of Wells Fargo from $72.00 to $75.00 and gave the stock an “overweight” rating in a research report on Friday, February 2nd. Keefe, Bruyette & Woods downgraded shares of Wells Fargo from an “outperform” rating to a “market perform” rating and set a $63.00 price target on the stock. in a research report on Sunday, February 4th. BMO Capital Markets restated a “hold” rating and set a $60.00 price target on shares of Wells Fargo in a research report on Monday, February 5th. Citigroup downgraded shares of Wells Fargo from a “buy” rating to a “neutral” rating and set a $65.00 price target on the stock. in a research report on Monday, February 5th. Finally, Royal Bank of Canada downgraded shares of Wells Fargo from an “outperform” rating to an “underperform” rating in a research report on Monday, February 5th. Six investment analysts have rated the stock with a sell rating, seven have issued a hold rating and sixteen have assigned a buy rating to the company. Wells Fargo presently has an average rating of “Hold” and an average target price of $61.83.

About Wells Fargo

Wells Fargo & Company, a diversified financial services company, provides retail, commercial, and corporate banking services to individuals, businesses, and institutions. The company's Community Banking segment offers checking and savings accounts; credit and debit cards; and automobile, student, mortgage, home equity, and small business loans.

Want to see what other hedge funds are holding WFC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Wells Fargo (NYSE:WFC).

Institutional Ownership by Quarter for Wells Fargo (NYSE:WFC)